Table 2.

Logistic regression analysis for association between Cav-1 and cSVD.

Cav-1	CMBs				SLIs				WMHs
	Model 1	P	Model 2	P	Model 1	P	Model 2	P	Model 1	P	Model 2	P
≤5.25 ng/mL	3.69 (1.78–7.64)	0.00044	4.05 (1.77–9.30)	0.001	1.30 (0.68–2.50)	0.431	1.61 (0.77–3.36)	0.209	0.88 (0.45–1.70)	0.696	0.77 (0.36–1.67)	0.510
>5.25 ng/mL	Reference		Reference		Reference		Reference		Reference		Reference

Model 1, adjusted for age and sex; Model 2, adjusted for age, sex, hypertension, diabetes mellitus, dyslipidemia, heart disease, BMI, smoking, alcohol intake, SBP, DBP, antithrombotics use, onset-to-MRI time, onset-to-blood drawing time, NIHSS, fasting glucose, triglycerides, HDL, LDL, total cholesterol, and fibrinogen.

CMBs, cerebral microbleeds; SLIs, silent lacunar infarcts; WMHs, white matter hyperintensities.